Stand Up to Cancer | GenomeWeb

Stand Up to Cancer

NEW YORK (GenomeWeb News) –The fundraising organization Stand Up To Cancer (SU2C) has provided a grant of €6 million ($8.1 million) to investigators at the Dutch Cancer Society and the American Association for Cancer Research to fund an effort to grow and study living tumors from patient samples

NEW YORK (GenomeWeb News) – A multi-organization initiative has been created with the goal of discovering new therapies for childhood cancers using genomics as well as immunotherapeutic technologies.

NEW YORK (GenomeWeb News) – The Prostate Cancer Foundation plans to use a $7 million donation from New York billionaire Stewart Rahr to fund a multi-partner research project that will use genomic medicine and other approaches to discover new prostate cancer treatments.

NEW YORK (GenomeWeb News) – A second Dream Team project has been created for translational research into prostate cancer with $10 million in funding over three years.

NEW YORK (GenomeWeb News) – A group of Dutch-led research partners will use a €1.2 million ($1.5 million) grant awarded under a collaboration with Stand Up 2 Cancer (SU2C) to fund a genomics-based project seeking to use tumor profiles to predict patient response to cancer treatments.

The multi-partner non-profit cancer research initiative has funded new high-risk, high-reward grants using exome sequencing, genomic analysis, and tumor-specific drug response studies.

These high-risk awards for young scientists will support epigenomics, molecular profiling, and other studies that could be "game-changers."

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.